4/A
Changes in Ownership
GYRE THERAPEUTICS, INC. Filed Acc 0001209191-15-085392
Options or other derivatives
- Chief Scientific Officer acquired 58,572 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Madison Edwin · Chief Scientific Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2015-10-22 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +58,572 | $4.40 | 2025-10-22 | 58,572 | 58,572 | D |
Loading xslF345X03/doc4a.xml…